Clinical trialNCT01478178CompletedPhase 1/PHASE2Interventional

Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma

SponsorKintara Therapeutics, Inc.Enrollment55Brain CancerGBMGlioblastomaGlioblastoma MultiformeGlioma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Gerald Falchook, M.D.
Sarah Cannon Research Institute; Denver, Colorado 80218 USA
Principal Investigator
clinicaltrials.gov ↗
Howard A Burris, M.D.
Sarah Cannon Research Institute; Nashville, Tennessee 37203, USA
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
Manish Patel, M.D.
Florida Cancer Specialists, Sarasota, Florida 34232, USA
Principal Investigator
clinicaltrials.gov ↗
Nicholas Butowski, M.D.
University of California, San Francisco, 94143, USA
Principal Investigator
clinicaltrials.gov ↗
Sani Kizilbash, M.D.
Mayo Clinic, Rochester, Minnesota 55905, USA
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of California, San Francisco, Division of Neuro-Oncology
San Francisco, California, United States
Sarah Cannon Research Institute
Denver, Colorado, United States
Florida Cancer Specialists
Sarasota, Florida, United States
Mayo Clinic
Rochester, Minnesota, United States
Sarah Cannon Research Institute
Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Dianhydrogalactitol

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Oct 2011
Primary completion: 31 Dec 2015
Completion: 31 Oct 2016
Last update posted: 29 Aug 2025
Registered enrollment: 55
Registry id: NCT01478178

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.